Effects of Xanthohumol on Resting Energy Expenditure and Substrate Oxidation in Healthy Women
NCT ID: NCT05711212
Last Updated: 2024-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
2023-02-15
2024-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigating a Natural Antioxidant Food Product on Oxidative Stress in Recreationally Active Participants
NCT04959006
Evaluate the Effectiveness and Safety of the Alpinia Galanga Formulation, Theacrine Formulation, and Caffeine Formulation on Fatigue, Mental Acuity, and Cognitive Health
NCT05170113
Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Chronic Heart Failure and Chronic Obstructive Pulmonary Disease Patients
NCT00852020
Pre-Sleep Creatine Enhances Anaerobic Power in Recreationally Active Females
NCT06937190
Dietary Supplementation on Fat Oxidation
NCT06548048
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Xanthohumol
single dose of 172 mg of micellar solubilized Xanthohumol
micellar solubilized Xanthohumol
single administration of 4 soft gelatine capsules each containing 43 mg micellar solubilized Xanthohumol
Placebo
Polysorbat 80 (E433)
Placebo
single administration of 4 soft gelatine capsules containing only micelles
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
micellar solubilized Xanthohumol
single administration of 4 soft gelatine capsules each containing 43 mg micellar solubilized Xanthohumol
Placebo
single administration of 4 soft gelatine capsules containing only micelles
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* metabolically healthy
* written consent
Exclusion Criteria
* low or high blood pressure
* dyslipidemia
* insulin resistance or diabetes mellitus type 1 or type 2
* gastrointestinal diseases (e.g. food intolerances or allergies)
* liver, kidney and/or thyroid diseases
* hepatitis B or C, HIV Infection
* chronic inflammatory diseases
* disordered eating
* psychological diseases
* alcohol and/or drug abuse
* use of medication
* pregnancy or lactating
* participation in another intervention study
* irregular menstrual cycle
* more than 6 hours of sports per week
18 Years
35 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Bonn
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. Sarah Egert
Prof. PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sarah Egert, Prof PhD
Role: PRINCIPAL_INVESTIGATOR
University of Bonn
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Bonn
Bonn, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
XN REE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.